Smruthi Organics Ltd.
Snapshot View

128.00 -1.45 ▼-1.1%

29 March 2023, 04:01:00 PM
Volume: 6,221

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.smruthiorganics.com
Market Cap 147.03 Cr.
Enterprise Value(EV) 152.55 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 4.45 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 28.88 Trailing Twelve Months Ending 2022-12
Industry PE 32.17 Trailing Twelve Months Ending 2022-12
Book Value / Share 58.54 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.19 Calculated using Price: 128.45
Dividend Yield 2.34 Period Ending 2022-03
No. of Shares Subscribed 1.14 Cr. 11,446,290 Shares
FaceValue 10
Company Profile
Smruthi Organics Ltd is a mid-size, public limited, API manufacturing company from Solapur, India. Smruthi Organics Ltd was established in1989 by qualified technocrats and has very good experience and reputation in the pharmaceutical industry for the supply of quality products.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.12%
1 Week
-0.78%
1 Month
+4.28%
3 Month
-26.65%
6 Month
-41.22%
1 Year
-45.68%
2 Year
-46.09%
5 Year
+287.88%
10 Year
+232.73%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -16.15 -11.83 2.41 5.03 -10.48 20.97 21.43 33.23 16.27
Return on Capital Employed (%) -4.60 -0.01 9.53 10.60 -0.96 21.54 25.00 39.08 20.99
Return on Assets (%) -4.83 -3.27 0.69 1.69 -3.79 7.42 8.96 19.05 11.57

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 35 29 31 32 29 36 42 60 67 67
Non Curr. Liab. 32 34 32 11 7 7 7 5 5 4
Curr. Liab. 58 44 39 42 48 57 38 26 15 34
Minority Int.
Equity & Liab. 126 107 102 85 84 101 88 92 88 105
Non Curr. Assets 67 61 58 41 33 36 35 33 35 37
Curr. Assets 59 47 44 44 51 65 53 59 52 69
Misc. Exp. not W/O
Total Assets 126 107 102 85 84 101 88 92 88 105

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 94 77 74 79 97 137 131 127 133 140
Other Income 1 0 0 1 0 1 4 1 1 0
Total Income 94 77 74 80 98 138 136 127 134 140
Total Expenditure -92 -72 -63 -69 -94 -121 -116 -98 -115 -129
PBIDT 2 5 11 11 3 17 20 29 19 11
Interest -5 -6 -5 -4 -4 -4 -3 -1 -1 -1
Depreciation -6 -5 -4 -4 -4 -4 -4 -4 -4 -4
Taxation 3 2 -1 -1 1 -3 -4 -7 -3 -1
Exceptional Items
PAT -6 -4 1 2 -3 7 8 17 10 5
Adjusted EPS -5 -3 1 1 -3 6 7 15 9 4

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 5 9 9 14 9 5 12 21 23 2
Cash Fr. Inv. -13 -2 -1 0 0 -3 -5 -5 -3 -6
Cash Fr. Finan. 6 -6 -8 -14 -9 -2 -5 -17 -7 -12
Net Change -1 2 -1 0 0 0 2 -1 13 -16
Cash & Cash Eqvt 1 2 2 2 2 2 4 4 16 1

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 63.50 63.39 63.39 63.39 63.39 63.39 63.51 63.51 63.51
Public 36.50 36.61 36.61 36.61 36.61 36.61 36.49 36.49 36.49
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 10 Feb 2023
Intimation Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015
We are pleased to inform you that our Companys Flagship API site has been successfully inspected by Ministry of Food and Drug Safety (MFDS) Republic of South Korea leading to the registration of our product in the Korean market. This positive outcome will enable the company to export its products to Republic of South Korea and several other signatory countries of the PIC/S scheme.
Thu, 09 Feb 2023
Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held Today I.E. Thursday 09Th February 2023.
Kindly note that the Board of Directors of the Company has in its meeting held today i.e. on Thursday 09th February 2023 ("said meeting") considered and approved the Unaudited Financial Results of the Company for the third quarter ended 31st December 2022.Further pursuant to the applicable provisions of SEBI Listing Regulations please find enclosed herewith: - (i) the Unaudited Financial Results; and (ii) Limited Review Report dated 09th February 2023 issued by the Statutory Auditors of the Company w.r.t. the Unaudited Financial Results and taken on record by the Board of Directors of the Company.
Thu, 09 Feb 2023
Unaudited Financial Results Of The Company For The Third Quarter Ended 31St December 2022.
Kindly note that the Board of Directors of the Company has in its meeting held today i.e. on Thursday 09th February 2023 ("said meeting") considered and approved the Unaudited Financial Results of the Company for the third quarter ended 31st December 2022.Further pursuant to the applicable provisions of SEBI Listing Regulations please find enclosed herewith: - (i) the Unaudited Financial Results; and (ii) Limited Review Report dated 09th February 2023 issued by the Statutory Auditors of the Company w.r.t. the Unaudited Financial Results and taken on record by the Board of Directors of the Company.

Technical Scans View Details >>

Wed, 29 Mar 2023
High Delivery Percentage High Delivery Percentage
Closing Below Previous Low Closing Below Previous Low
High Decrease in 3 Months High Decrease in 3 Months
High Decrease in 6 Months High Decrease in 6 Months
High Decrease in 1 Year High Decrease in 1 Year

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 237,702.12 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 76,011.65 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,827.63 2,818.70 +0.5%
Cipla Ltd. 71,662.87 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,756.97 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,113.83 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,628.37 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.44 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.86 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.22 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 82.20 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.32 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.08 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.30 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.45 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 6.01 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.19 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.25 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On Smruthi Organics Ltd.

What is Smruthi Organics share price?

Can I buy Smruthi Organics shares now?

What is the Dividend Yield of Smruthi Organics?

What is the Market Cap of Smruthi Organics?

What are the key metrics to analyse Smruthi Organics?

What is the 52 Week High and Low of Smruthi Organics?

What is the trend of Smruthi Organics share price?